4Kaoru Nakamura. Monocyte-mediated Cytotoxicity on bladder cancer cells in vitro and its implication in the treatment of bladder cancer patients with bacillus calmette-gu 6 rin[J]. The Keio Journal of Medicine, 2009, 33 (4) : 185-199.
5Gandhi N M, Morales A, Lamm D L. Bacillus Calmette-Gu 6 rin immunotherapy for genitourinary cancer[J]. BJU lnt, 2013, 112 ( 3 ): 288-297.
6Kawai K, Miyazaki J, Joraku A, et al. Bacillus Calmette-Guerin ( BCG ) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine[J]. Cancer Sci ,2013, 104( 1 ): 22-27.
8Pan Feng Shang, Joey Kwong, Zhi Ping Wang, et al. Intravesical Bacillus Calmette-Gu e rin versus epirubicin for Ta and T1 bladder cancer[J]. Cochrane Database of Systematic Reviews, 2011, 11 ( 5 ): 1-46.
9Jong-Wei Hsu, Michael R. King. Applications of nanotechnology in bladder cancer therapy[J]. Journal of Healthcare Engineering, 2012, 3 ( 4 ) : 535-550.
